Atlas Trials

Transplantation Infection

32 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Transplantation Infection

RecordFirmDate
Improving Immunization Rates in Transplant Candidates Through the Use of a Health Information Technology Tool (NCT04336735)University of Colorado, Denver2022-01-01
Description of Lung Transplant Patients With Microbiologically Documented Stenotrophomonas Maltophilia Pneumonia and Impact of Treatment on Outcome (NCT05193058)Fondation Hôpital Saint-Joseph2021-11-22
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients (NCT05198570)University of Pisa2021-09-15
Bacillus Clausii in Liver Transplantation (NCT05047406)Ain Shams University2021-09-07
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients (NCT04613206)Vanderbilt University Medical Center2021-01-11
Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study (NCT04579471)Universitaire Ziekenhuizen KU Leuven2020-07-01
CMV Infection and Immune Intervention After Transplantation (NCT04320303)Peking University People's Hospital2020-03-23
Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients (NCT04281797)Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology2020-01-01
Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients. (NCT03699254)Maimónides Biomedical Research Institute of Córdoba2019-04-05
Prevention of Healthcare Associated Infections in Bone Marrow Transplant Patients (NCT02463214)University of British Columbia2015-09-01
The Role of B Cells in Kidney Allograft Dysfunction (NCT02294032)Loma Linda University2014-08-28
ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation (NCT01972035)University of Minnesota2014-08-01
Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A (NCT02328963)University Hospital, Bordeaux2014-05-02
Resistant Bacterial Infections in the Early Post LDLT Period (NCT02777632)Ain Shams University2014-01-01
Determinants of Immunosuppressive Dose Requirements in Children After Solid Organ Transplantation (NCT01767350)Universitaire Ziekenhuizen KU Leuven2013-02-01
Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant (NCT02084446)Ronaldo de Matos Esmeraldo, MD2012-12-01
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies (NCT01471067)M.D. Anderson Cancer Center2012-07-13
Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis (NCT01295645)M.D. Anderson Cancer Center2011-03-17
Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation (NCT01515605)Odense University Hospital2011-01-01
Graft Take and Microbiology in Burns (NCT01301118)Federal University of São Paulo2010-10-01
TransplantLines Food and Nutrition Biobank and Cohort Study (TxL-FN) (NCT02811835)University Medical Center Groningen2008-11-01
Induction Related BK Viremia in Renal Transplant Patients (NCT00610961)University of Florida2007-10-01
Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation (NCT00473824)ADMA Biologics, Inc.2007-05-01
Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients (NCT01276457)Novartis Pharmaceuticals2006-05-01

Track Transplantation Infection automatically

Every clearance here is in the API, with alerts when new ones post.